titanium dioxide chromatography

Show results for

Proteomics (161)
Unknown (44)
Other (1)
Metabolomics (1)

Organisms

Bombyx mori (153)
Schizosaccharomyces pombe (153)
Human immunodeficiency virus 1 (153)
Oryza sativa Indica Group (153)
Sinorhizobium meliloti BL225C (153)
Sus scrofa domesticus (153)
Ostreococcus tauri (153)
Saccharomyces cerevisiae (153)
Vitis vinifera (153)
Staphylococcus aureus (153)
Rattus norvegicus (153)
Escherichia coli (153)
Candida albicans (153)
Cyanophora paradoxa (153)
Bursaphelenchus xylophilus (153)
Pseudomonas aeruginosa SJTD-1 (153)
Rhizobium sp. Leaf68 (153)
Canis lupus familiaris (153)
Camelus dromedarius (153)
Entamoeba histolytica (153)
Physcomitrium patens (153)
Methylohalobius crimeensis 10Ki (153)
Pseudomonas putida BIRD-1 (153)
Homo sapiens (153)
Carya cathayensis (153)
Taeniopygia guttata (153)
Lotus japonicus (153)
Homo sapiens (4)
Felis catus (1)
cellular organisms (1)

Repository

pride (153)
jPOST (4)
iProX (2)
MassIVE (2)
GPMDB (1)
LINCS (1)
MetaboLights (1)

Tissue

Cell culture (36)
Epithelial cell (12)
Brain (10)
Fibroblast (8)
Heart (7)
Permanent cell line cell (7)
T cell (6)
Embryonic stem cell (5)
Cell suspension culture (5)
Lung (5)
Spleen (4)
Hepatocyte (4)
Skeletal muscle (3)
Whole body (3)
Liver (3)
CD8-positive (2)
Astrocyte (2)
Keratinocyte (2)
B cell (2)
Blood cell (2)
Blood (2)
Craniofacial region (1)
Monocyte-derived dendritic cell (1)
Forebrain (1)
Heart ventricle (1)
Endometrial microvascular endothelial cells (1)
Generation of neurons (1)
RAW-264.7 cell (1)
Neuron apoptotic process (1)
HUVEC cell (1)

Disease

Breast cancer (5)
Acute leukemia (4)
Prostate cancer (3)
Cardiovascular system disease (2)
Brain cancer (2)
Disease free (2)
Not Available (1)
Ataxia telangiectasia (1)
Rhabdoid cancer (1)
Myeloma (1)
Arrhythmogenic right ventricular cardiomyopathy (1)
Diffuse midline glioma (1)
Prostate cancer (1)
Myotonic dystrophy type 1 (1)
Anthrax disease (1)
Heart disease (1)
Neck carcinoma (1)
Medulloblastoma (1)
Skin cancer (1)
Hepatocellular carcinoma (1)
Plasmodium falciparum malaria (1)
Severe acute respiratory syndrome (1)
Lung adenocarcinoma (1)
Osteosarcoma (1)
Prostate adenocarcinoma (1)
Mixed disorder as reaction to stress (1)
Multiple myeloma (1)
Pancreatic ductal adenocarcinoma (1)
Lung cancer (1)
Neuroblastoma (1)

Technology Type

Mass Spectrometry (153)
Shotgun proteomics (106)
Bottom-up proteomics (24)
Data-dependent acquisition (16)
Chemical cross-linking coupled with mass spectrometry proteomics (9)
Affinity purification coupled with mass spectrometry proteomics (7)
Gel-based experiment (6)
Top-down proteomics (3)
Data-independent acquisition (2)
Mass spectrometry assay (1)
Affinity proteomics (1)
DiaPASEF (1)
SWATH MS (1)

Instrument Platform

Instrument (1)
Q Exactive (1)
Q Exactive HF (1)
Liquid Chromatography MS - alternating - reverse-phase (1)

Publication Date

2026 (19)
2024 (18)
2020 (17)
2022 (16)
2021 (15)
2017 (12)
2016 (12)
2019 (11)
2025 (9)
2018 (9)
2023 (9)
2015 (8)
2014 (3)
2013 (2)

Metabolite Name

(2S)-1-[(2S)-2-[(5-methoxy-1-methylindole-2-carbonyl)amino]-3-methylbutanoyl]pyrrolidine-2-carboxylic acid (1)
Methyl 2-[(4-hydroxyphenyl)methylene]-3-oxobenzo[b]furan-5-carboxylate (1)
(19E)-4-Ethyl-2,16-Didehydrocur-19-En-4-Ium-17-Al (1)
1H,1H,2H,2H-Perfluorohexanol (1)
Ethyl 5-hydroxy-2-methyl-1-[2-(4-propylphenoxy)ethyl]benzo[g]indole-3-carboxyl ate (1)
(E)-N-butyl-N-(1-(cyclohexylamino)-1-oxobutan-2-yl)but-2-enamide (1)
Ethyl 3-nitrocinnamate (1)
NCGC00386084-01_C23H32N2O3_ (1)
2-Chloro-N-[2-(5-Methoxy-2-Methyl-1H-Indol-3-Yl)Ethyl]-5-Nitrobenzamide (1)
5-[(E)-3-hydroxybut-1-enyl]-4-[4-[(E)-3-oxobut-1-enyl]anilino]oxolan-2-one (1)
5-chloro-2,4-dihydroxy-3-[(E)-4-hydroxy-3-methyl-5-(1,2,6-trimethyl-3-oxocyclohexyl)pent-2-enyl]-6-methylbenzaldehyde (1)
3,5-Dichlor-lecanorsaeure-methylester (1)
Dihydroyashabushiketol (1)
9-methyl-8-{[3-(trifluoromethyl)phenyl]methylthio}hydropurin-6-one (1)
(1S,4R,5S,23S,26S)-26-hydroxy-4,5,13,13,15,15,31,31-octamethyl-14,32,33-trioxa-7-azanonacyclo[28.2.1.01,27.04,26.05,23.06,21.08,20.010,18.011,16]tritriaconta-6(21),8(20),9,11,16,18,27-heptaen-29-one (1)
3-{3-[(3-chloro-4-fluorophenyl)amino]propanoyl}chromen-2-one (1)
Iodohippuric acid (1)
Mmv676470 (1)
14-Chloro-2, 8, 10-trihydroxy-3, 11(13)-guaiadien-12, 6-olide (1)
N-(4-fluorophenyl)-2-(6-oxo-9-phenylhydropurin-8-ylthio)acetamide (1)
3-Hydroxydesloratadine (1)
3,3-dimethyl-11-(4-prop-2-ynyloxyphenyl)-2,3,4-trihydro-5H,10H,11H-benzo[1,2-f ]benzo[b]1,4-diazepin-1-one (1)
2-(2-acetylbenzimidazolyl)-N-[2-(3,4-dimethoxyphenyl)ethyl]acetamide (1)
Diphenidol Hydrochloride (1)
Mls001148620 (1)
6-Hydroxyangolensic acid methyl ester (1)
Rev 5901 (1)
Methyl 3-phenyl-2-(phenylformamido)propanoate (1)
2-[2-oxo-4-(piperidylcarbonyl)hydroquinolyl]-N-(2-phenylethyl)acetamide (1)
Pheniramine maleate salt (1)

Modification

2x(15)N labeled L-lysine (3)
4x(15)N labeled L-arginine (3)

Release Date

2019 (6)
2013 (6)
2011 (5)
2023 (4)
2021 (4)
2022 (3)
2016 (3)
2014 (3)
2018 (2)
2015 (2)
2020 (1)
2017 (1)
2012 (1)
2010 (1)
2009 (1)

Lab affiliation

ETH Zurich, Institute of Molecular Systems Biology (4)
The University of Sydney (3)
ETH Zurich, Institute of Molecular Systems Biology, Zurich, Switzerland (3)
Plateforme protéomique 3P5-Necker, Université Paris Descartes - Structure Fédérative de Recherche Necker, INSERM US24/CNRS UMS3633, Paris 75014, France (2)
Flinders Health and Medical Research Institute, College of Medicine and Public Health, Flinders University, Adelaide, Australia (2)
Novo Nordisk Foundation Center for Protein Research Faculty of Health & Medical Sciences University of Copenhagen Blegdamsvej 3B DK-2200 Copenhagen N Denmark (2)
Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch (2)
Division of Cell Signalling and Immunology, School of Life Sciences, University of Dundee, Dundee, UK (2)
Center for Molecular Medicine University Medical Center Utrecht Utrecht 3584CG The Netherlands (2)
Department of Biochemistry and Functional Proteomics, Institute of Biology II, Faculty of Biology and BIOSS Centre for Biological Signalling Studies, University of Freiburg (2)
Leibniz-Institut für Analytische Wissenschaften – ISAS – e.V. (2)
EDyP (2)
Amsterdam UMC, Vrije Universiteit Amsterdam, Medical Oncology, Cancer Center Amsterdam, OncoProteomics Laboratory, Amsterdam, Netherlands (2)
Prof Matthias Trost Chair of Proteomics Newcastle University Faculty of Medical Sciences Institute for Cell and Molecular Biosciences Framlington Place Newcastle-upon-Tyne NE2 4HH, UK (1)
Center for Integrative Genomics, University of Lausanne, Lausanne, Switzerland (1)
Department of Biochemistry and System Biology, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, L69 7ZB, UK (1)
Goethe University Frankfurt, University Hospital, Clinic of Neurology, Exp. Neurology, Heinrich Hoffmann Str. 7, 60590 Frankfurt am Main, Germany (1)
Cancer Signalling Research Group, School of Biomedical Science and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, NSW, AUSTRALIA. Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, NSW, AUSTRALIA. (1)
University Clinic of Frankfurt Medical Clinic I Biomedical Research Laboratory Germany (1)
Institute for Microbiology, Department of Microbial Proteomics, Ernst Moritz Arndt University Greifswald, Germany (1)
Department of Physiology, University of Toronto Ted Rogers Centre for Heart Research Toronto, Ontario, Canada (1)
Mass Spectrometry Proteomics The Francis Crick Institute Midland Road London NW1 1AT UK (1)
Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, MD 20205, USA (1)
Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern, Switzerland Department for BioMedical Research (DBMR), University of Bern, Switzerland (1)
University of Minnesota, Twin-Cities, Pharmacology Department (1)
University of Minnesota, Twin-cities Pharmacology Department (1)
Prof. Bettina Warscheid Funktionelle Proteomik Biologie II Albert-Ludwigs-Universität Freiburg Schänzlestr. 1 79104 Freiburg (1)
Proteomics Unit, Spanish Cancer Research Centre, Madrid, Spain (1)
Group Leader, GIMM, Lisbon, Portugal (1)
Chemistry Department, University of Alberta (1)

Previous page
1 / 21
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 21
Next page

Sort by:

Relevance

Page size

Off-line high pH reversed-phase fractionation for in-depth phosphoproteomics

In this study we provide a detailed analysis of the physicochemical characteristics of phosphopeptides, which have been fractionated by off-line high pH chromatography (HpH) before subsequent titanium dioxide (TiO2) enrichment and LC-MS/MS analysis. Our results demonstrate that HpH is superior to st...

ORGANISM(S): Mus musculus (Mouse)

2014-10-23 | PXD001404 | Pride

Refined phosphopeptide enrichment by phosphate additive and the analysis of human brain phosphoproteome.

Data from ProteomeXchange, PXD ID: PXD001180. File: tio2_250ug.mzml. Published as part of Proteomics. 2015 Jan;15(2-3):500-7 . From the Abstract: {{i}} Here, we report a pilot investigation of AD phosphoproteome by titanium dioxide enrichment coupled with high resolution LC-MS/MS. During the optimi...

ORGANISM(S): Homo_sapiens_viruses, Human

GPM11210034774 | GPMDB

Resource Reanalysis

Determination of Histamine in Silages Using Nanomaghemite Core (γ-Fe₂O₃)-Titanium Dioxide Shell Nanoparticles Off-Line Coupled with Ion Exchange Chromatography.

Not available

S-EPMC5036737 | biostudies-literature

iTRAQ-based Quantitative Phosphoproteomics Revealed Differences in Phosphorylation Modification Between Different Toxoplasma gondii Genotypes

iTRAQ technology combine with titanium dioxide (TiO2) affinity chromatography was applied to investigate the phosphoproteomic difference between type I (RH) strain, type II Prugniuad (PRU) strain and Chinese 1 (PYS) strain genotypic tachyzoites of T. gondii

ORGANISM(S): Toxoplasma gondii

2019-11-14 | PXD007777 | Pride

Phosphoproteomics Tachyzoite Differentially expressed phosphoprotein (dpp) Toxoplasma gondii Genotype Itraq

Effects of titanium dioxide (TiO2) nanoparticles (NPs) on endothelial cells

The widespread commercial use of TiO2-NPs, such as in medical stents, has led to extensive investigations on their toxicity and biological impact but lacks a detailed study on their effects. Proteomics and transcriptomics are key methodologies to unravel cellular dynamics, macromolecular interaction...

ORGANISM(S): Homo sapiens (Human)

2019-01-16 | PXD005359 | Pride

Endothelial cells Nanoparticles Titanium dioxide

Molecular Omics Unveils the Antimicrobial Mechanism of UV-LED-Induced Chitosan Composite Film Against Penicillium itali-cum

Penicillium italicum (P. italicum) is a primary pathogen responsible for postharvest decay in citrus fruits, resulting in substantial economic losses. Chitosan and titanium dioxide and silver (CTS&TiO2&Ag) composite film solutions activated by combined UV and LED light represent innovativ...

2026-06-08 | MTBLS14711 | MetaboLights

Centromere protection requires strict mitotic inactivation of the Bloom syndrome helicase complex

The BTRR (BLM/TOP3A/RMI1/RMI2) complex resolves various DNA replication and recombination intermediates to suppress genome instability. Alongside PICH, they target mitotic DNA intertwinements, known as ultrafine DNA bridges, facilitating chromosome segregation. Both BLM and PICH undergo transient mi...

ORGANISM(S): Homo sapiens (Human)

2025-08-12 | PXD052669 | Pride

Chromosome biorientation Bloom syndrome helicase Cdk1 Mps1 Pich Plk1 Ultrafine dna bridge (ufb)-binding complex Pp1s Rif1 Anaphase dna bridges Centromeres Btrr dissolvasome

Surfactant-coupled titanium dioxide coated iron-aluminium mixed metal hydroxide for magnetic solid phase extraction of bisphenols in carbonated beverages.

Not available

S-EPMC8111676 | biostudies-literature

Interaction of TiO2 nanoparticles with lung fluid proteins and the resulting macrophage inflammatory response

Inhalation is a major nanoparticle exposure pathway. Following inhalation, nanoparticles first interact with the lung lining fluid, a complex mixture of proteins, lipids, and mucins. We measure the concentration and composition of lung fluid proteins adsorbed on the surface of titanium dioxide (TiO2...

ORGANISM(S): Mus musculus (Mouse)

2023-11-10 | PXD041036 | Pride

Titanium dioxide Bronchoalveolar lavage Nanoparticles Inhalation Murine Protein corona

Quantitative Temporal Phosphoproteomic Profiling of KBU2046 Treated Human Prostate Cancer Cells

This project details a quantitative phosphoproteomic analysis of PC3 cells treated with the compound KBU2046. The study evaluated cellular responses to vehicle control, 1 µM KBU2046, and 10 µM KBU2046 at three time points (15 minutes, 1 hour, and 4 hours) using three biological replicates per condit...

ORGANISM(S): Homo sapiens (Human)

2026-09-03 | PXD077844 | Pride

Previous page
1 / 21
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 21
Next page

Sort by:

Relevance

Page size

207 Results

Show results for

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

Metabolite Name

Modification

Release Date

Lab affiliation

OmicsDI is part of the ELIXIR infrastructure

Tweets